To test whether downregulation of TMEM106B expression altered the in vivo metastatic potencies, the syngeneic mouse lung cancer cell lines (344SQ and 344LN) with TMEM106B knockdown or Control (Scramble) were injected subcutaneously in syngeneic mice. Here, TMEM106B is linked to lung cancer.